Allarity Therapeutics, Inc. Preferred Stock, Par or Stated Value Per Share
Allarity Therapeutics, Inc. (ALLR) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2025-03-31
- 2024-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2024-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2023-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2023-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-04-21 | $1080.00 10-K · filed 2024-03-08 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-14 |
| 2021-12-31 | $0.00 10-K · filed 2022-05-17 |
| 2021-09-30 | $0.00 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |